Morepen Laboratories Limited (NSE:MOREPENLAB)
India · Delayed Price · Currency is INR 48.47
-0.37 (-0.76%)
Oct 27, 2025, 3:30 PM IST
Morepen Laboratories Market Cap
Morepen Laboratories has a market cap or net worth of 26.56 billion as of October 27, 2025. Its market cap has decreased by -42.21% in one year.
Market Cap
26.56B
Enterprise Value
26.65B
Revenue
18.01B
Ranking
n/a
PE Ratio
28.69
Stock Price
48.47
Market Cap Chart
Since October 8, 1999, Morepen Laboratories's market cap has increased from 8.66B to 26.56B, an increase of 206.82%. That is a compound annual growth rate of 4.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 27, 2025 | 26.56B | -38.08% |
| Dec 31, 2024 | 42.90B | 72.95% |
| Dec 29, 2023 | 24.81B | 28.39% |
| Dec 30, 2022 | 19.32B | -23.70% |
| Dec 31, 2021 | 25.33B | 83.39% |
| Dec 31, 2020 | 13.81B | 97.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.06T |
| Divi's Laboratories | 1.75T |
| Cipla | 1.28T |
| Apollo Hospitals Enterprise | 1.13T |
| Zydus Lifesciences | 1.02T |
| Mankind Pharma | 997.51B |
| Fortis Healthcare | 794.63B |
| Alkem Laboratories | 662.99B |